$Eledon Pharmaceuticals (ELDN.US)$Reuters· 2 mins ago Eledon Pharmaceuticals Announces Positive Initial Data From Subjects With Type 1 Diabetes Treated With Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at Uchicago Medicine
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more